clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Intense Ultrasound Releases Cancer Biomarkers, Allows for Earlier Cancer Detection
Molecular Dx
Genetic Variant Linked to Cardiovascular Disease and Death in Black Americans
News & Features
Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s…
News & Features
Ultra-Low Energy MRI Shows Its Potential
News & Features
Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Enlaza Nets $100M to Advance Covalent Biologics Platform
Small molecules
News & Features
Enlaza Nets $100M to Advance Covalent Biologics Platform
Malorye Branca
-
May 1, 2024
0
News & Features
AI That Predicts Targeted Cancer Drug Response with Single-Cell Precision
Malorye Branca
-
April 18, 2024
0
News & Features
Obsidian Raises $160M+ to Advance Novel Solid Tumor Immunotherapy
Malorye Branca
-
April 5, 2024
0
News & Features
Novo Nordisk Inks $1.46B Deal with Neomorph for Molecular Glue Degraders
Malorye Branca
-
February 27, 2024
0
News & Features
DeepMind’s Isomorphic Inks $3B Worth of Deals with Lilly and Novartis in One Day
Malorye Branca
-
January 8, 2024
0
News & Features
Oral Cyclic Peptides Synthesized in Advance for Drug Discovery
Malorye Branca
-
December 28, 2023
0
News & Features
Depixus and Daiichi Sankyo Collaborate to Produce RNA-Targeted Drugs
Helen Albert
-
December 12, 2023
0
News & Features
Ajinomoto Acquires Gene Therapy Manufacturer for More than $550M
Malorye Branca
-
November 15, 2023
0
News & Features
In Potential $2B Deal, AstraZeneca Licenses Oral GLP-1 Agonist for Weight Loss
Malorye Branca
-
November 9, 2023
0
News & Features
Five Key Precision Medicine Players With Products in the Market
Jonathan Smith
-
October 18, 2023
0
1
2
Page 1 of 2
Related Content
Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine
Zenas Nets $200M to Advance mAb for Autoimmune Diseases
Cancer-Like Features in Atherosclerosis Provide New Opportunity for Treatment
Walgreens Dives into Gene and Cell Therapy Delivery
Inside Precision Medicine